Brief: Dancann Pharma Says Shareholder Xignotus As A Result Of Acquisition Of Canngros Has Crossed Flagging Limit Of 25%
20/10/2021 16:49
Oct 20 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* SHAREHOLDER XIGNOTUS' HOLDING IN COMPANY, AS A RESULT OF
ACQUISITION OF CANNGROS APS HAS CROSSED FLAGGING LIMIT OF 25
PERCENT
* FOLLOWING TRANSACTIONS, XIGNOTUS HAS NOW 21.65 PERCENT OF
VOTES
AND CAPITAL IN COMPANY
Source text for Eikon: ID:nWkr5KC0HS
Further company coverage: DANCAN.TE
((reuters.briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874